Acneiform eruption caused by levonorgestrel-intrauterine system: a case report

Authors

  • Kiymet Handan Kelekci
  • Sefa Kelekci

DOI:

https://doi.org/10.66344/jpad.22.1.2012.908

Keywords:

Acne, acneiform eruption, androgen, LNG-IUS, treatment

Abstract

Acneiform eruptions occur from a wide variety of diseases, including infections, hyperandrogenism and drug reactions. The levonorgestrel-intrauterine system (LNG-IUS) provides highly effective contraception by releasing levonorgestrel into the uterine cavity. We present a woman with acneiform eruption after insertion of the LNG-IUS for contraceptive purposes which resolved shortly after its removal. In reproductive age women with acneic eruption with unknown ordinary cause, LNG-IUS should be ascertained as a cause of acne 

References

ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008;14:197-208.

Beck E, Progestin-only contraception. West J Med 1991;154:327.

Cohen EB, Rossen NN. Acne vulgaris in connection with the use of progestogens in a hormonal IUD or a subcutaneous implant. Ned Tijdschr Geneeskd 2003;147:37-39.

Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990;22:85-90.

Nilsson CG, Luukkainen T, Arko H. Endometrial morphology of women using a D-norgestrel releasing intrauterine device. Fertil Steril 1978;29:397-401.

C Fedele L, Bianchi S, Zancomoto G et al. Use of levonorgestrel-releasing intrauterine system in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485-8.

Dubuissona JB, Mugnierb E. Acceptability of the levonorgestrel-releasing-intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35 to 45 years. Contraception 2002;66:1218.

Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel-intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-9.

Downloads

Published

2017-01-04

How to Cite

1.
Kelekci KH, Kelekci S. Acneiform eruption caused by levonorgestrel-intrauterine system: a case report. J Pak Assoc Dermatol [Internet]. 2017Jan.4 [cited 2026May3];22(1):76-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/908

Issue

Vol. 22 No. 1 (2012): January - March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.